Drug Therapy for Non-Alcoholic Steatohepatitis-Induced Liver Fibrosis
Aim. An overview of current pharmacotherapy for non-alcoholic steatohepatitis (NASH)-associated liver fibrosis.Key points. In current clinical recommendations, therapeutic measures in non-alcoholic fatty liver disease should include lifestyle change, body weight normalisation, NASH-associated liver...
Guardat en:
| Autor principal: | |
|---|---|
| Format: | Artigo |
| Idioma: | Russo |
| Publicat: |
Gastro LLC
2022-01-01
|
| Col·lecció: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
| Matèries: | |
| Accés en línia: | https://www.gastro-j.ru/jour/article/view/646 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|